CardioDiagnostics, founded in 2010, is a biotechnology startup based in the United States that integrates IT and Internet technologies into the healthcare sector. Their slogan, "Know More. Save Time. Heal Better," encapsulates their mission to transform cardiovascular health management.
The company is pioneering in developing hardware-agnostic digital solutions for diagnosing and managing heart diseases—today's leading cause of death globally. Their technology supports patients throughout the care continuum, from symptom onset to ongoing management, positioning CardioDiagnostics as a significant player in patient empowerment and engagement.
Having last secured a Series A investment on 02 September 2016 with backing from Cedar Mundi Ventures, the company presents a compelling opportunity for investors looking to tap into the healing potential of digital therapeutics in healthcare.